1. Introduction {#sec1}
===============

Diet may play a substantial role in the Alzheimer\'s disease (AD) symptomatology and offer great potential for nonpharmacological prevention. Epidemiological evidence has suggested increased adherence to a Mediterranean diet [@bib1], low glycemic index [@bib2], [@bib3], and higher consumption of omega-3 polyunsaturated fatty acids [@bib4] were associated with a decrease in AD biomarker burden. Systematic review found 50 out of 64 studies revealed an association between diet and AD incidence [@bib5]; however, only one study has used *a priori* analysis to analyze dietary associations with the hallmark cerebral protein implicated in AD, β-amyloid (Aβ). In this study, dietary pattern analysis identified a pattern characterized by a higher intake of fresh fruit, vegetables, whole grains, fish, and low-fat dairies, and a lower intake of sweets, fried potatoes, processed meat, and butter was negatively associated with *in vivo* cerebral Aβ [@bib6].

Furthermore, male and mixed cohort studies predominate the research, and to date, no study has investigated this relationship specifically in women. Women are more likely than men to develop AD [@bib7], have a higher penetrance for the apolipoprotein ε-4 (APOE-ε4) allele [@bib8], and are more likely to progress from mild cognitive impairment to AD [@bib8]. Impacts of higher male mortality, vascular risk factors, and the postmenopausal loss of estrogenic neuroprotection suggest females are 1.5 times more likely to develop AD than men [@bib9]. Given sex differences in AD risk, research is needed for those at greater risk of disease.

Studies investigating *in vivo* AD biomarkers are needed to clarify how nutrition promotes healthy brain aging and to identify neuroprotective patterns for those at the greatest risk of AD. The objectives of this study were to identify dietary patterns using an *a priori* approach and investigate their associations with Aβ deposition in healthy aging Australian women. We previously reported on a lack of a relationship between a healthy Mediterranean diet and Aβ deposition [@bib10] and hypothesized this was due to limitations of the self-reported food frequency questionnaire in measuring the potentially beneficial phytochemicals in olive oil. Given high-fat, high-glycemic diets have been associated with increased AD biomarker burden, we hypothesized that a dietary pattern characterized by high-fat, high-sugar content would be associated with an increase in cerebral Aβ pathology.

2. Methods {#sec2}
==========

2.1. Study population {#sec2.1}
---------------------

Participants were sought from the 2012 follow-up of the Women\'s Health Ageing Project (WHAP), an epidemiologically sourced prospective study of healthy aging Australian women. WHAP is an extension of the Melbourne Women\'s Midlife Health Project. Briefly, 438 women within the Melbourne metropolitan area were identified by random digit dialing in 1991. Women were eligible for the cohort if they were Australian-born, aged 45--55 years, had menstruated in the three months before recruitment, and were not taking estrogen-containing hormone replacement therapy. In 2012, participants were re-contacted and invited to participate in a late-life health study. Clinical assessments were conducted on 252 participants by trained field researchers. The clinical assessments included a battery of validated measures of physical health, sociodemographics, lifestyle, cognitive function, psychological health, and biomarkers. A complete methodology has been published elsewhere [@bib11].

2.2. Diet {#sec2.2}
---------

Participants completed a validated food frequency questionnaire entitled the Dietary Questionnaire for Epidemiological Studies Version 2 (DQES v2) [@bib12]. The DQES v2 incorporates 80 food items with frequency response options on 74 of these items. The DQES v2 covers five types of dietary intake: cereals/sweets/snacks, dairy/meat/fish, fruits, vegetables, and alcoholic beverages. Data collected by the DQES v2 was used to calculate daily energy and nutrient intakes by the Cancer Council of Victoria based on Australian nutrient composition data from NUTTAB95, collated via the Composition of Foods, Australia [@bib13]. Individuals were removed if their energy intake was reported as below 3000 kJ/day or above 20,000 kJ/day. All food items were reported in grams per day and placed into 33 food groups defined *a priori* ([Table 1](#tbl1){ref-type="table"}) that was similar to those used by others [@bib14], [@bib15]. Dietary patterns were extrapolated from food groupings using iterated principal factor analysis with oblique varimax rotation due to the presumed intercollinearity and nonindependence of dietary patterns.Table 1Food groupings from Dietary Questionnaire for Epidemiological Studies Version 2 (DQES v2)Food groupItems in the DQES v2Whole grainsAll bran, bran flakes, high fiber white bread, muesli, multigrain bread, porridge, rye bread, Weet-Bix, wholemeal breadRefined grainsCorn flakes, crackers, pasta, rice, white breadRed meatsBeef, lamb, pork, vealProcessed meatsBacon, salami, sausagesPoultryChickenTakeaway foodsHamburger, meat pies, pizzaFried fishFried fishOther fishFish (nonfried), tinned fishFried potatoesChips (French fries)Other potatoPotatoesYellow or red vegetablesCapsicum, carrots, pumpkinLegumesBaked beans, green beans, other beans, peas, tofuCruciferous vegetablesBroccoli, cabbage, cauliflowerLeafy green vegetablesLettuce, spinachOther vegetablesBean sprouts, beetroot, celery, cucumber, garlic, mushrooms, onion, zucchiniTomatoTomatoesFresh fruitApples, apricots, avocado, bananas, mango, melon, oranges, peaches, pears, pineapple, strawberriesCanned fruitTinned fruitCakes, biscuits, sweet pastriesCakes, sweet biscuitsLow-fat dairy productsFlavored milk drink, low-fat cheese, reduced fat milk, ricotta cheese, cottage cheese, skim milkFull-fat dairy productsCream cheese, firm cheese, full-cream milk, hard cheese, ice cream, soft cheese, yoghurtSoya milkSoya milkConfectioneryChocolateAdded sugarJam, sugarCrispsCrispsNutsNuts, peanut butterEggsEggsFruit juiceFruit juiceSaturated spreadsButter, butter-margarine blends, margarineUnsaturated spreadsMonounsaturated margarine, polyunsaturated margarineAlcohol--beerHeavy beer, light beerAlcohol--wineRed wine, white wineAlcohol--spiritsFortified wines, spirits

2.3. Imaging {#sec2.3}
------------

In the 2012 follow-up, all WHAP participants were offered the opportunity to have cerebral imaging. Aβ deposition was measured via *in vivo* F-18 Florbetaben positron emission tomography (PET) at the Austin Health Centre for PET in Victoria, Australia. Participants received 250 MBq of 18F-florbetaben intravenously, with a 20-minute acquisition commencing 90 minutes after injection. Standardized uptake values (SUVs) were calculated for all brain regions examined, and standard uptake value ratios (SUVRs) were generated by normalizing regional SUVs by the cerebellar cortex with atrophy correction from structural magnetic resonance imaging. Neocortical SUVR, a global index of Aβ burden, is expressed as the average SUVR of the area-weighted mean. Area-weighted means were calculated for each participant by averaging the frontal, superior parietal, lateral temporal, lateral occipital, and anterior and posterior cingulate regions. This protocol has been described elsewhere [@bib11].

2.4. Covariates {#sec2.4}
---------------

Age (in years), education (in years), and body mass index (BMI) were collected as part of the clinical assessments in 2012. Total energy intake in kilojoules was calculated by the Cancer Council of Victoria from the DQES v2. The Consortium to Establish a Registry for Alzheimer\'s Disease (CERAD) Savings Score was used as a valid indicator of cognitive ability [@bib16]---it has been suggested as the most reliable index in differentiating cognitively normal individuals from AD [@bib17]. Participants\' APOE genotype was determined by direct sequencing and were dichotomized as an APOE ε4 carrier (APOE ε2/ε4, APOE ε3/ε4, and APOE ε4/ε4) or a noncarrier. Adherence to identified dietary patterns was converted from weighted factor loadings to binary adherence to minimize the intracorrelations between variables. All analyses were adjusted for age in years, education in years, energy intake (kJ/day), cognition (CERAD Savings), and binary presence of the APOE ε4 allele.

2.5. Statistical analysis {#sec2.5}
-------------------------

All analyses were conducted in STATA software on Windows operating system. Complete data were available for 115 WHAP participants, and there were no significant differences between the included (n = 115) and excluded (n = 137) cohorts. PET SUVRs displayed a positive skew that was rectified using 1/square transformation; therefore, results should be interpreted as inverse coefficient derivatives. Generalized linear models were used to assess associations between Aβ deposition and dietary patterns scores. Generalized linear models were adjusted for age in years, education in years, cognition (CERAD Savings), and binary presence of the APOE ε4 allele.

3. Results {#sec3}
==========

Four dietary patterns were identified: high fat, Mediterranean, junk food, and low fat. Factor loadings ([Table 2](#tbl2){ref-type="table"} and [Fig. 1](#fig1){ref-type="fig"}) indicated that the high-fat diet loaded heavily on food groups such as processed meats, fried fish, red meats, fried potatoes, and poultry. The Mediterranean style diet loaded chiefly on whole grains, vegetables, nuts, fish, and wine as the main source of alcohol. The unhealthy junk food pattern was characterized by high consumption of takeaway foods, added sugar, confectionary and cakes, biscuits, and sweet pastries, whereas the low-fat diet loaded heavily on low-fat dairy products, vegetables, and unsaturated spreads.Table 2Dietary pattern factor loadings for all WHAP participants in 2012 (n = 224)VariableHigh fatMediterraneanJunk foodLow fatEigenvalue3.038022.136231.807381.55595Variance2.152522.006481.581081.39511Proportion0.31640.29490.23240.2051Whole grains0.36680.20960.1387Refined grains0.15980.16730.1247Red meats0.54640.1128Processed meats0.7281Poultry0.41300.13020.1549Takeaway foods0.2021−0.25430.3427Fried fish0.46620.2473Other fish0.40290.3867Fried potatoes0.4195Other potato0.18030.11270.3143Yellow or red vegetables0.16750.25940.14800.5034Legumes0.29230.3134Cruciferous vegetables0.2117−0.10270.4114Leafy green vegetables0.5466Other vegetables0.19610.68690.1286Tomato−0.24590.2255Fresh fruit−0.27860.33810.1887Canned fruit0.1337Cakes, biscuits, sweet pastries0.6350Low-fat dairy products−0.22220.5117Full-fat dairy products0.17540.1255−0.4775Soya milk0.1843−0.1101Confectionery−0.11950.24840.5211Added sugar0.12630.4327Crisps0.14050.1229Nuts0.44850.1703Eggs0.10830.1448Fruit juice−0.1134Saturated spreads−0.2113Unsaturated spreads0.2165Alcohol--beer0.1540−0.1618−0.1272Alcohol--wine0.13450.1586−0.2868[^1]Fig. 1Spider diagram of factor loadings by dietary patterns.

Participants\' characteristics are found in [Table 3](#tbl3){ref-type="table"}. Participants in the Mediterranean diet group (n = 31) displayed the highest level of education (14.10 ± 3.87 years), highest CERAD Savings score (72.97 ± 31.07), and lowest level of Aβ deposition (PET SUVR 1.0834 ± 0.14). Daily energy intake was highest in the high-fat group (5443.46 ± 2116.50 kJ/day) and lowest in the Mediterranean group (4677.26 ± 1242.79 kJ/day). Significant group differences were observed in education, energy intake, and CERAD Savings and were therefore adjusted for in all generalized linear models.Table 3Descriptive statistics for the included participants grouped by adherence to dietary patterns identified using IPFAVariableHigh fat (n = 24)Mediterranean (n = 31)Junk food (n = 24)Low fat (n = 35)Total (n = 115)Age (in years)69.79 ± 2.4269.45 ± 2.2370.41 ± 3.1969.57 ± 2.7069.76 ± 2.63Education (in years)12.88 ± 3.6714.10 ± 3.8711.50 ± 2.9612.63 ± 3.3612.84 ± 3.57BMI28.58 ± 6.7527.43 ± 5.4827.14 ± 5.5829.29 ± 4.2628.18 ± 5.46Energy (kJ/day)5443.46 ± 2116.504809.79 ± 1145.516035.40 ± 1993.214677.26 ± 1242.795160.53 ± 1679.03APOE positive, n (%)9 (37.5)9 (29.0)9 (37.5)10 (28.57)37 (32.46)CERAD Savings Score (%)72.93 ± 18.0872.97 ± 31.0765.57 ± 28.7663.34 ± 28.6268.45 ± 27.52PET SUVR (raw)1.1296 ± 0.15391.0835 ± 0.14271.2150 ± 0.24581.1300 ± 0.23361.1352 ± 0.2026PET SUVR (transformed)0.8185 ± 0.17700.8829 ± 0.16460.7389 ± 0.21740.8446 ± 0.20430.8273 ± 0.1959[^2][^3]

Adherence to the junk food diet ([Table 4](#tbl4){ref-type="table"}) was a significant predictor of Aβ deposition (β = .10, *P* = .036) as was binary presence of the APOE ε4 allele (β = .11, *P* = .004). No significant interaction effects were observed in the combined effect of diet and APOE ε4 on Aβ deposition (*P* = .59). All other dietary patterns were not associated with Aβ deposition. Age, education, and cognition were also not significantly associated with Aβ deposition.Table 4Generalized linear model for independent variables (PET SUVR) and four dietary patterns identified using iterative principal factor analysis. (95% CIs shown; n = 114)PET SUVRCoefficientStd. Err.*P*CI lowerCI higherHigh fat−0.007050.04372.872−0.092730.07864Mediterranean0.063900.04349.142−0.021350.14915Junk food−0.097400.04511**.031**−0.18582−0.00898Low fat0.023380.03962.555−0.054280.10103Age (in years)−0.001200.00702.864−0.014950.01256Education (in years)0.001390.00502.781−0.008450.01125BMI−0.000760.00326.816−0.007140.00563Energy (kJ/day)−0.000010.00001.309−0.000030.00001APOE Presence−0.109160.03919**.005**−0.18598−0.03233CERAD Savings Score0.001250.00065.054−0.000020.00252[^4][^5]

4. Discussion {#sec4}
=============

In this cross-sectional study in Australian women, adherence to the junk food was a significant predictor of cerebral Aβ deposition. These results suggest that higher adherence to a high-fat, high-sugar style diet may be associated with an increased deposition of AD biomarkers and a higher risk for disease.

We observed similar cognitive status between dietary groups. However, women adhering to the Mediterranean dietary pattern displayed significantly higher cognitive scores than the other dietary groups. In the longitudinal Nurse\'s Health Study, women with higher Mediterranean diet adherence had significantly higher overall cognitive status [@bib18]. Given evidence for the cardiovascular determinants of cognitive decline [@bib19], [@bib20], there is clear evidence for an inverse relationship between Mediterranean diet adherence and cognition; however, the cross-sectional nature of this study limits our ability to address this relationship.

Our results contribute to the growing body of evidence linking diet with AD. A high-glycemic diet has been associated with greater amyloid burden in the brain [@bib2] and cerebrospinal fluid measures [@bib3], [@bib21], [@bib22]. A principal component analysis on nutrient intake patterns showed consumption of omega-3 fatty acids, zinc, vitamin B-12, and vitamin D was associated with decreased amyloid deposition [@bib6], [@bib23]. Consumption of omega-3 fatty acid supplementation has been shown to be related to tau (phosphorylated and total) and amyloid biomarkers of AD in cerebrospinal fluid [@bib24]. Serum docosahexaenoic acid has also been inversely associated with cerebral amyloid burden [@bib25].

Research has established that diets with higher consumption of sugar, carbohydrates, and high-glycemic foods are associated with impaired glucose metabolism [@bib26]. Disrupted glucose metabolism affects the production and clearance of Aβ and tau phosphorylation [@bib27], and both insulin resistance [@bib28] and type-2 diabetes [@bib29] are risk factors for AD. Several animal studies have illustrated that a high-fat diet causes brain Aβ accumulation in wild-type rabbits [@bib30] and transgenic mice [@bib31], [@bib32]. Furthermore, human APOE isoforms have been shown to modulate glucose and metabolic pathways, with the APOE ε3/ε4 variants showing markedly reduced glucose uptake and metabolism in mouse models [@bib33]. APOE ε2 brains demonstrated a more robust metabolic profile than APOE ε3/ε4, suggesting a physiological mechanism for its protective role against AD [@bib33].

We speculate that the relationship observed between a high-fat, high-sugar diet and increased cerebral Aβ deposition may be modulated by impaired glucose metabolism in this female-only cohort. We believe our results suggest an impaired glucose metabolic pathway interacting with an APOE-Aβ physiological mechanism. Research has been shown that APOE ε4 confers a greater risk in women than men [@bib8]. Women with a single APOE ε4 allele have up to a four-fold increase in risk when compared with women homozygous for APOE ε3; however, men with a single APOE ε4 allele have little to no increase in risk [@bib34]. Given animal model evidence for an APOE-mediated glucose metabolism [@bib33], females may experience greater AD risk due to a mechanistic action in their glucose metabolism. Further research is required to elucidate the physiological mechanisms that underpin this relationship, for example, to replicate animal evidence of glucose metabolism in human models of APOE ε4 isoforms.

Our findings strengthen the hypothesis of diet being a modifiable risk factor for AD by linking amyloid deposition with an unhealthy-type diet in a female-only cohort. These findings suggest a metabolic pathway linking diet with cerebral Aβ deposition and should motivate investigations into dietary impacts on glucose metabolism by variations in presence of the APOE ε2/ε3/ε4 alleles.Research in Context1.Systematic review: The authors previously conducted a systematic review that highlighted the paucity of research regarding dietary adherence and biomarkers of Alzheimer\'s disease. This review was conducted in accordance with PRISMA guidelines (PROSPERO: CRD42017076389) searching MEDLINE, PubMed, PsycINFO, Google Scholar, and SCOPUS databases.2.Interpretation: Our findings contribute to the growing body of evidence linking diet with Alzheimer\'s disease. We speculate that the relationship observed between a high-fat, high-sugar diet and increased cerebral β-amyloid deposition is affected by impaired glucose metabolism. These findings suggest an apolipoprotein E (APOE)--mediated glucose metabolic pathway.3.Future directions: Our research suggests a metabolic pathway linking diet with cerebral Aβ deposition and should motivate investigations into dietary impacts on glucose metabolism and Alzheimer\'s disease biomarker deposition by variations in presence of the APOE ε2/ε3/ε4 alleles.
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[^1]: Rotated factor loadings for iterated principal factor analysis with oblique promax rotation. Blanks represent absent loadings (\<0.1). Alcohol--spirits not shown due to not loading (\>0.1) on any factor.

[^2]: Abbreviations: APOE, apolipoprotein E; BMI, body mass index; CERAD, Consortium to Establish a Registry for Alzheimer\'s Disease; PET, positron emission tomography; SUVR, standard uptake value ratio.

[^3]: NOTE. If not otherwise described, data are presented as mean ± standard deviation of the mean.

[^4]: Abbreviations: APOE, apolipoprotein E; BMI, body mass index; CERAD, Consortium to Establish a Registry for Alzheimer\'s Disease; CI, confidence interval; PET, positron emission tomography; SUVR, standard uptake value ratio.

[^5]: NOTE. Bold indicates statistical significance (*P* \< .05). CIs are for coefficient. Analysis adjusted for age in years, education in years, cognition (CERAD Savings score), and binary presence of the APOE ε4 allele.
